NSCLC STAGE IIIB~IV

Clinical trials for NSCLC STAGE IIIB~IV explained in plain language.

Never miss a new study

Get alerted when new NSCLC STAGE IIIB~IV trials appear

Sign up with your email to follow new studies for NSCLC STAGE IIIB~IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New combo tackles resistant lung cancer in small trial

Disease control Completed

This phase 2 study tested a combination of four drugs—atezolizumab, bevacizumab, a platinum drug, and pemetrexed—in 22 people with advanced EGFR-mutant non-small cell lung cancer whose disease had progressed after EGFR-targeted therapy. The goal was to see how many patients' tumo…

Matched conditions: NSCLC STAGE IIIB~IV

Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

NSCLC STAGE IIIB~IV

Get alerted when new NSCLC STAGE IIIB~IV trials appear

New combo tackles resistant lung cancer in small trial